MAPT and Alzheimer disease: Such studies could involve comparing the levels of these lncRNAs in different cell types, tissue samples, or animal models, and examining how their expression correlates with AD-specific pathological features, such as amyloid plaque formation, tau tangles, and neuroinflammation.